Cell and gene therapy: Creating connections amid complexity

FierceBiotech

Product developments in cell and gene therapy are both among the most groundbreaking and the most complex. Cell and gene therapy product launch success hinges on investment in the right technology and data solutions, and that also means finding the right partner.

In speaking with Fierce Pharma, Doug Cook, president of commercialization services and animal health, explained his role in manufacturer offerings, from the clinical trials stage to consulting through patient support and payer strategy. Hear more from Cook in his interview with Fierce Pharma.